FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/03/018061 [Registered on: 13/03/2019] Trial Registered Prospectively
Last Modified On: 12/03/2019
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A study to compare and assess a new technique to remove foreign material in respiratory tract in children through bronchoscopy  
Scientific Title of Study   A Comparative Evaluation of a Novel Technique for Bronchoscopy Guided Tracheobronchial Foreign Body Removal in Children-A Randomised Controlled Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Richa Rai 
Designation  Senior Resident  
Affiliation  Institute of Medical Sciences-Banaras Hindu University 
Address  Department of Anesthesiology, Sir Sunderlal Hospital, Institute of Medical Sciences-Banaras Hindu University(IMS-BHU), Varanasi.

Varanasi
UTTAR PRADESH
221005
India 
Phone  9452516982  
Fax    
Email  richasgpgi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Richa Rai 
Designation  Senior Resident  
Affiliation  Institute of Medical Sciences-Banaras Hindu University 
Address  Department of Anesthesiology, Sir Sunderlal Hospital, Institute of Medical Sciences-Banaras Hindu University(IMS-BHU), Varanasi.

Varanasi
UTTAR PRADESH
221005
India 
Phone  9452516982  
Fax    
Email  richasgpgi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Richa Rai 
Designation  Senior Resident  
Affiliation  Institute of Medical Sciences-Banaras Hindu University 
Address  Department of Anesthesiology, Sir Sundarlal Hospital, Institute of Medical Sciences-Banaras Hindu University(IMS-BHU), Varanasi.

Varanasi
UTTAR PRADESH
221005
India 
Phone  9452516982  
Fax    
Email  richasgpgi@gmail.com  
 
Source of Monetary or Material Support  
Dr.Richa Rai, Department of Anesthesiology, Sir Sunderlal Hospital, Institute of Medical Sciences-Banaras Hindu University(IMS-BHU), Varanasi, Uttar Pradesh. 
 
Primary Sponsor  
Name  Richa Rai 
Address  Department of Anesthesiology, Sir Sunderlal Hospital, Institute of Medical Sciences-Banaras Hindu University 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NONE   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Richa Rai  Sir Sunderlal Hospital  Department of Pediatric Surgery, Operating Room 1 and 2, Institute of Medical Sciences-Banaras Hindu University(IMS-BHU).
Varanasi
UTTAR PRADESH 
9452516982

richasgpgi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: X58||Exposure to other specified factors,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  0.9% normal saline for placebo purpose  Nebulisation and transtracheal block will be done by 0.9% normal saline 10-15 min prior to bronchoscopy 
Intervention  2ml of 2% lignocaine(nebulization) and 1 ml of 2% plain lignocaine(transtracheal block)  Nebulization will be done with 2ml of 2% xylocaine for 10-15 minutes prior to bronchoscopy. After that , transtracheal block will be done with 1 ml of 2% plain lignocaine 10 minutes prior to procedure. 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  5.00 Year(s)
Gender  Both 
Details  1.ASA grade I to II
2.Recent H/O of tracheobronchial foreign body aspiration
3.Parents giving consent for participation in the study 
 
ExclusionCriteria 
Details  1.Bronchoscopy through tracheostomy
2.Anterior neck swelling
3.Known allergy to local anesthetics
4.Renal, hepatic, or cardiovascular dysfunction, neurological disorders
5.Mental retardation or delayed milestones
6.Suspected coagulopathy
7.Parents refusal to participate in the study 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1.To compare the effect on intra-procedure and post-procedure hemodynamics
(Heart Rate, Non-Invasive Blood Pressure) and oxygen saturation.
2.Total dose of propofol used during procedure in both the groups.
3.Post-procedure recovery 
Heart rate,Non-invasive blood pressure and saturation will be recorded continuously every 3 minutes throughout the procedure and till return of consciousness. 
 
Secondary Outcome  
Outcome  TimePoints 
To look for complications encountered in such procedures like airway intervention, bronchospasm, laryngospasm, vocal cord injury and laryngeal or subglottic odema in both groups.  Complications noted from start of bronchoscopy till completion of procedure and return of consciousness every 5 minutes 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   01/04/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   30 patients will be randomly divided into 2 groups. Patients will be premedicated with 0.05 mg/kg and glycopyrrolate 10 mcg/kg. Induction will be done in both groups with fentanyl 2 mcg/kg and propofol 1-2 mg/kg in titrated dose before the start of procedure. 

Group A - Patients will be nebulized with 2ml of 2% lignocaine for 10-15 minutes in preoperative room before induction. After induction, transtracheal block will be done with 1 ml of 2% plain lignocaine 10 minutes prior to procedure.

Group B - Nebulisation and airway block will done with normal saline for blinding purpose.

Immediately followed by infusion of propofol @50-150 mcg/kg/min for maintenance anesthesia. We will use rescue propofol intermittently depending upon the patients’ requirements. Rigid bronchoscopy will be performed by pediatric surgeons in all cases . HR, SPO2 and NIBP will be recorded
   continuously every 3 minutes throughout the procedure and patient will be observed for any event of desaturation or other adverse effects. All patients will be maintained on the spontaneous ventilation. After completion of procedure and stopping anesthetics, we will note the time duration of return to full consciousness and baseline saturation with any eventful episodes. To monitor recovery of consciousness at the end of procedure , MOAA(Modified Observers Assessment of Alertness/Sedation) scale will be used .  
 
Close